Venture Round - ILiAD Biotechnologies
Investment Firm
Overview
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Announced Date
Dec 19, 2018
Funding Type
Series Unknown
Highlights
Location
New York, New York, United States, North America
Social
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Network-1 |
Round Details and Background
ILiAD Biotechnologies raised $20000000 on 2018-12-19 in Venture Round
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 06, 2022 |  Series D - ILiAD Biotechnologies | 1 | - | 42.8M |
| Jan 01, 2014 | Seed Round - ILiAD Biotechnologies | 1 | - | undefined |
| Aug 16, 2016 | Seed Round - ILiAD Biotechnologies | - | 545.8K | |
| Nov 13, 2015 | Debt Financing - ILiAD Biotechnologies | - | 640.0K |
Recent Activity
There is no recent news or activity for this profile.